Induction of immunity against lethal Haemophilus influenzae type b infection by Escherichia coli core lipopolysaccharide.
about
New developments in the treatment of gram-negative bacteremia.Administration in vivo of recombinant interleukin 2 protects mice against septic death.Phase I study of a murine monoclonal anti-lipid A antibody in bacteremic and nonbacteremic patients.In vitro and in vivo evaluation of A-56268 (TE-031), a new macrolideAnalysis of toxinogenic functions associated with the RTX repeat region and monoclonal antibody D12 epitope of Escherichia coli hemolysin.A murine monoclonal antibody defines a unique epitope shared by Klebsiella lipopolysaccharides.Assessment of ability of murine and human anti-lipid A monoclonal antibodies to bind and neutralize lipopolysaccharide.Antibodies to lipooligosaccharide of a Brazilian purpuric fever isolate of Haemophilus influenzae biogroup aegyptius lack bactericidal and protective activity.Antigenic diversity of lipooligosaccharides of nontypable Haemophilus influenzae.Lipid X ameliorates pulmonary hypertension and protects sheep from death due to endotoxin.Complexing of bacterial lipopolysaccharide with lung surfactant.Composition and antigenic activity of the oligosaccharide moiety of Haemophilus influenzae type b lipooligosaccharideCharacterization of murine monoclonal antibodies to Escherichia coli J5Participation of complement in host defense against capsule-deficient Haemophilus influenzae.Further studies of the role of noncapsular antibody in protection against experimental Haemophilus influenzae type b bacteremia.Antibody specific for Escherichia coli J5 cross-reacts to various degrees with an Escherichia coli clinical isolate grown for different lengths of time.Protective ability and specificity of convalescent serum from calves with Haemophilus somnus pneumonia.Mechanisms involved in protection provided by immunization against core lipopolysaccharides of Escherichia coli J5 from lethal Haemophilus pleuropneumoniae infections in swine.Mouse monoclonal antibodies reactive with J5 lipopolysaccharide exhibit extensive serological cross-reactivity with a variety of gram-negative bacteria.Partial protection against Brucella infection in mice by immunization with nonpathogenic alphaproteobacteria.Lethal Haemophilus influenzae type b infection in mice.
P2860
Q34193370-DEDDBF6F-4A75-4CA9-A0CB-68D7FC87882BQ34576288-8A03C5CF-EFD7-48A1-9361-6BD0B3BD98DDQ35304730-840E5704-251B-4282-9B18-8C64DE821D7AQ35653665-2C49DAF6-B101-4D1A-AA19-D484427E2CF8Q35773269-E5B1B8ED-3C5B-4B65-A3D3-4F959C83E1A1Q35776524-F3DA3863-D748-43DB-8C64-DD10FE0CC253Q36361146-5F2C9E8B-471F-474E-BC5D-E7A7A5F584EDQ36949903-622AEBD5-D394-4CB7-98A8-BC023DDEC417Q37017712-DC6A4318-069F-4DC6-9D11-AB3253E8873EQ37024140-E569954B-BA5A-4410-87C5-020E9D7FEC67Q37027051-8AA2579E-EEDF-40DE-A732-71871B8685BAQ37034989-46383C45-CB4D-4C75-B478-EAE39F88DAA5Q37053753-DC065895-A49C-456F-8803-76622647162FQ37102516-2D389BEB-6B39-4F77-9005-F16AB3B94690Q37104077-1B465280-AC27-49AE-BDF6-45AE7E359DAFQ40163051-94EDD0C3-53DE-4448-B562-A3D8A4FAE15BQ40163375-E5F0ABAA-101F-4D4B-9329-BC1DEB5DB9D6Q40165057-8296734A-1E57-41D6-83DD-CBB94AC99F24Q40168635-0AEA7743-CBA0-4E7E-92D2-F30CB6DF55C4Q42909254-CE64AF10-9664-4914-8B73-82AB07BA558DQ48905276-62342394-72DE-4F63-B3E7-2525BFE81BB2
P2860
Induction of immunity against lethal Haemophilus influenzae type b infection by Escherichia coli core lipopolysaccharide.
description
1982 nî lūn-bûn
@nan
1982年の論文
@ja
1982年論文
@yue
1982年論文
@zh-hant
1982年論文
@zh-hk
1982年論文
@zh-mo
1982年論文
@zh-tw
1982年论文
@wuu
1982年论文
@zh
1982年论文
@zh-cn
name
Induction of immunity against ...... coli core lipopolysaccharide.
@en
type
label
Induction of immunity against ...... coli core lipopolysaccharide.
@en
prefLabel
Induction of immunity against ...... coli core lipopolysaccharide.
@en
P2093
P2860
P356
P1476
Induction of immunity against ...... coli core lipopolysaccharide.
@en
P2093
A I Braude
E J Ziegler
L B Corbeil
P2860
P304
P356
10.1172/JCI110512
P407
P577
1982-04-01T00:00:00Z